16-80633070-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BS1BS2
The NM_152342.4(CDYL2):c.783G>A(p.Thr261=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00158 in 1,614,142 control chromosomes in the GnomAD database, including 24 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.0083 ( 9 hom., cov: 32)
Exomes 𝑓: 0.00088 ( 15 hom. )
Consequence
CDYL2
NM_152342.4 synonymous
NM_152342.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -2.44
Genes affected
CDYL2 (HGNC:23030): (chromodomain Y like 2) Predicted to enable transcription corepressor activity. Predicted to be involved in negative regulation of transcription, DNA-templated. Predicted to be active in nucleus. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -19 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.45).
BP6
Variant 16-80633070-C-T is Benign according to our data. Variant chr16-80633070-C-T is described in ClinVar as [Benign]. Clinvar id is 784661.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-2.43 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.00828 (1261/152282) while in subpopulation AFR AF= 0.0286 (1189/41548). AF 95% confidence interval is 0.0273. There are 9 homozygotes in gnomad4. There are 570 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High AC in GnomAd4 at 1261 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
CDYL2 | NM_152342.4 | c.783G>A | p.Thr261= | synonymous_variant | 3/7 | ENST00000570137.7 | |
CDYL2 | XM_011522866.2 | c.885G>A | p.Thr295= | synonymous_variant | 3/7 | ||
CDYL2 | XM_011522867.3 | c.774G>A | p.Thr258= | synonymous_variant | 3/7 | ||
CDYL2 | XM_024450151.2 | c.606G>A | p.Thr202= | synonymous_variant | 3/7 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
CDYL2 | ENST00000570137.7 | c.783G>A | p.Thr261= | synonymous_variant | 3/7 | 1 | NM_152342.4 | P4 |
Frequencies
GnomAD3 genomes AF: 0.00829 AC: 1262AN: 152164Hom.: 9 Cov.: 32
GnomAD3 genomes
AF:
AC:
1262
AN:
152164
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00214 AC: 539AN: 251304Hom.: 12 AF XY: 0.00158 AC XY: 214AN XY: 135820
GnomAD3 exomes
AF:
AC:
539
AN:
251304
Hom.:
AF XY:
AC XY:
214
AN XY:
135820
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000879 AC: 1285AN: 1461860Hom.: 15 Cov.: 31 AF XY: 0.000785 AC XY: 571AN XY: 727238
GnomAD4 exome
AF:
AC:
1285
AN:
1461860
Hom.:
Cov.:
31
AF XY:
AC XY:
571
AN XY:
727238
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00828 AC: 1261AN: 152282Hom.: 9 Cov.: 32 AF XY: 0.00766 AC XY: 570AN XY: 74460
GnomAD4 genome
AF:
AC:
1261
AN:
152282
Hom.:
Cov.:
32
AF XY:
AC XY:
570
AN XY:
74460
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
5
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 31, 2019 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at